Zoetis Inc. (NYSE:ZTS) Stock Holdings Raised by Telos Capital Management Inc.

Telos Capital Management Inc. grew its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 4.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 42,706 shares of the company's stock after purchasing an additional 1,776 shares during the period. Telos Capital Management Inc.'s holdings in Zoetis were worth $6,958,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Oakworth Capital Inc. increased its stake in Zoetis by 1.5% in the fourth quarter. Oakworth Capital Inc. now owns 5,618 shares of the company's stock valued at $915,000 after purchasing an additional 82 shares during the last quarter. Financial Advocates Investment Management grew its holdings in Zoetis by 81.8% in the 4th quarter. Financial Advocates Investment Management now owns 6,273 shares of the company's stock valued at $1,022,000 after buying an additional 2,822 shares during the period. Legacy CG LLC acquired a new position in shares of Zoetis during the 4th quarter valued at about $4,400,000. Bleakley Financial Group LLC lifted its holdings in shares of Zoetis by 15.0% during the 4th quarter. Bleakley Financial Group LLC now owns 12,351 shares of the company's stock worth $2,012,000 after acquiring an additional 1,612 shares during the period. Finally, YANKCOM Partnership acquired a new stake in shares of Zoetis in the fourth quarter worth approximately $473,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ZTS has been the topic of a number of recent analyst reports. Leerink Partnrs raised shares of Zoetis to a "strong-buy" rating in a research note on Monday, December 2nd. Stifel Nicolaus cut their target price on Zoetis from $210.00 to $180.00 and set a "buy" rating on the stock in a research report on Tuesday, January 7th. UBS Group began coverage on Zoetis in a report on Monday, December 9th. They issued a "neutral" rating and a $196.00 target price on the stock. Leerink Partners started coverage on Zoetis in a research note on Monday, December 2nd. They set an "outperform" rating and a $215.00 price target for the company. Finally, JPMorgan Chase & Co. lifted their price objective on Zoetis from $225.00 to $230.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Zoetis currently has an average rating of "Buy" and a consensus price target of $215.00.

Zoetis Stock Down 1.6 %

NYSE ZTS traded down $2.75 on Friday, reaching $171.37. The company had a trading volume of 1,927,109 shares, compared to its average volume of 2,620,628. The firm has a market capitalization of $77.32 billion, a PE ratio of 32.21, a P/E/G ratio of 2.72 and a beta of 0.90. The firm has a 50-day moving average of $169.34 and a 200-day moving average of $179.28. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $200.53. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.12. The firm had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The firm's quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.36 EPS. On average, equities research analysts anticipate that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date of this dividend is Monday, April 21st. Zoetis's payout ratio is 37.59%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.